Kairos Pharma (KAPA) vs Matinas Biopharma (MTNB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Kairos Pharma is the larger company by market cap ($3.2 million vs $2.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KAPA | MTNB |
|---|---|---|
| Share price | $0.9595 | $2.83 |
| Market cap | $3.25M | $2.77M |
| 1-day change | +10.29% | +2.17% |
| EPS (TTM) | $-2.16 | $-17.93 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.24 | $28.95 |
| 52-week low | $0.848 | $2.27 |
| Distance from 52-week high | -89.62% | -90.22% |
| Analyst consensus | none | — |
| Avg. price target upside | +5006.83% | — |
| Average volume | 602.89K | 408.10K |
| Shares outstanding | 3.39M | 979.52K |
| Employees | 1 | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Kairos Pharma
KAPA stock →Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Healthcare · Biotechnology · 1 employees
About Matinas Biopharma
MTNB stock →Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.
Healthcare · Biotechnology · 2 employees
KAPA vs MTNB FAQ
Which is bigger, Kairos Pharma or Matinas Biopharma?
Kairos Pharma (KAPA) is larger, with a market capitalization of $3.25M compared with $2.77M for Matinas Biopharma (MTNB).
Are Kairos Pharma and Matinas Biopharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.